Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Brems-Eskildsen AS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Asbjørn Due, Tobias Berg, Maj-Britt Jensen, Sophie Yammeni, Lone Volmer, Anne Sofie Brems-Eskildsen, Klaus Kaae Andersen, Saeeda Rana, Ann Knoop, Iben Kümler
Publikováno v:
Due, A, Berg, T, Jensen, M-B, Yammeni, S, Volmer, L, Brems-Eskildsen, A S, Andersen, K K, Rana, S, Knoop, A & Kümler, I 2023, ' A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients ', Acta Oncologica, vol. 62, no. 2, pp. 126-133 . https://doi.org/10.1080/0284186X.2023.2176257
Background: Current guidelines in HER2-positive metastatic breast cancer (mBC) recommend the combination of trastuzumab and a chemotherapeutic agent for 3rd line or later treatments. This study aims to describe the treatment of HER2-positive mBC in 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fdae1238291c95b8c578fd876afeb8
Autor:
Brems-Eskildsen, Anne Sofie1, Linnet, Søren2, Danø, Hella3, Luczak, Adam4, Vestlev, Peter Michael5, Jakobsen, Erik Hugger6, Neimann, Jeppe1, Jensen, Charlotte Buch1, Dongsgaard, Trine2, Langkjer, Sven Tyge1
Publikováno v:
Acta Oncologica. Feb2021, Vol. 60 Issue 2, p157-164. 8p. 1 Diagram, 5 Charts, 1 Graph.
Autor:
Brems-Eskildsen, A.S., Kenholm, J., Brixen, A.T.L., Rønlev, J.D., Stenbygaard, L.E., Danoe, H., Grunnet, M., Jakobsen, E.H., Neimann, J., Geisler, J., Glavicic, V., Langkjer, S.T.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S376-S376
Autor:
Anja Bille Bohn, Thomas Wittenborn, Anne Sofie Brems-Eskildsen, Tinne Laurberg, Lotte Bonde Bertelsen, Thomas Nielsen, Hans Stødkilde-Jørgensen, Bjarne Kuno Møller, Michael R Horsman
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110091 (2014)
The vascular disrupting agent combretastatin A-4 disodium phosphate (CA4P) induces fluctuations in peripheral blood neutrophil concentration. Because neutrophils have the potential to induce both vascular damage and angiogenesis we analyzed neutrophi
Externí odkaz:
https://doaj.org/article/21e0b07b9d484657b7b20f35874a04a4
Autor:
Charlotte Buch Jensen, Peter Michael Vestlev, Erik Jakobsen, Hella Danø, Sven Tyge Langkjer, T. Dongsgaard, Adam Luczak, J. Neimann, Anne Sofie Brems-Eskildsen, Søren Linnet
Publikováno v:
Brems-Eskildsen, A S, Linnet, S, Danø, H, Luczak, A, Vestlev, P M, Jakobsen, E H, Neimann, J, Jensen, C B, Dongsgaard, T & Langkjer, S T 2021, ' Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer ', Acta Oncologica, vol. 60, no. 2, pp. 157-164 . https://doi.org/10.1080/0284186X.2020.1851045
Background: Metronomic treatment is hypothesized to be less toxic and more effective as compared to standard maximal tolerable dosing treatment in metastatic cancer disease. Material and methods: We tested the metronomic treatment principle with vino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2101a4cbcc0032e69ac0121949ed806f
https://vbn.aau.dk/da/publications/76bfbc2e-c9a4-4913-af91-571e16566305
https://vbn.aau.dk/da/publications/76bfbc2e-c9a4-4913-af91-571e16566305
Autor:
Brems-Eskildsen, Anne Sofie1 (AUTHOR) sofie@brems-eskildsen.dk, Kristoffersen, Kristina Bak2 (AUTHOR) sofie@brems-eskildsen.dk, Linnet, Søren3 (AUTHOR), Lörincz, Tamás2 (AUTHOR), Langkjer, Sven Tyge1 (AUTHOR)
Publikováno v:
Acta Oncologica. Jan2019, Vol. 58 Issue 1, p119-121. 3p. 2 Charts, 1 Graph.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Langkjer, Sven Tyge, Kenholm, Julia, Jensen, Jeanette Dupont, Wedervang, Kim, Torbøl Brixen, Annette, Grunnet, Mie, Stenbygaard, Lars, Gilje, Bjørnar, Danø, Hella, Glavicic, Vesna, Hugger Jacobsen, Erik, Brems-Eskildsen, Anne Sofie, Lemvig Kruse, Helle, Dongsgaard, Trine, Neimann, Jeppe, Geisler, Jürgen
Publikováno v:
Langkjer, Sven Tyge Kenholm, Julia Jensen, Jeanette Dupont Wedervang, Kim Torbøl Brixen, Annette Grunnet, Mie Stenbygaard, Lars Gilje, Bjørnar Danø, Hella Glavicic, Vesna Hugger Jacobsen, Erik Brems-Eskildsen, Anne Sofie Lemvig Kruse, Helle Dongsgaard, Trine Neimann, Jeppe Geisler, Jürgen . The NAME trial: a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer. Future Oncology. 2019, 15(22), 2561-2569
Future Oncology
Future Oncology
Externí odkaz:
http://hdl.handle.net/10852/77735
https://www.duo.uio.no/bitstream/handle/10852/77735/2/fon-2019-0124.pdf
https://www.duo.uio.no/bitstream/handle/10852/77735/2/fon-2019-0124.pdf
Autor:
T. Dongsgaard, Sven Tyge Langkjer, Lars Stenbygaard, Helle Lemvig Kruse, Julia Kenholm, Anne Sofie Brems-Eskildsen, Jeanette Dupont Jensen, Hella Danø, Bjørnar Gilje, Kim Wedervang, J. Neimann, Jürgen Geisler, Erik Hugger Jacobsen, Vesna Glavicic, Mie Grunnet, Annette Torbøl Brixen
Publikováno v:
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : A direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Chemotherapy for metastatic breast cancer (MBC) is in general given in cycles of maximum tolerated doses to potentially maximize the therapeutic outcome. However, when compared with targeted therapies for MBC, conventional and dose intensified chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3e68144dbea7113137cab419868c36
http://hdl.handle.net/10852/77735
http://hdl.handle.net/10852/77735